Evolent Health, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | $0.23 | $0.25 | $0.24 |
| Q2 2024 | 2 | $0.24 | $0.24 | $0.24 |
| Q3 2024 | 3 | $0.30 | $0.32 | $0.31 |
| Q4 2024 | 8 | $0.06 | $0.10 | $0.07 |
| Q1 2025 | 4 | $0.21 | $0.24 | $0.22 |
| Q2 2025 | 2 | $0.22 | $0.25 | $0.24 |
| Q3 2025 | 2 | $0.27 | $0.30 | $0.28 |
| Q4 2025 | 2 | $0.28 | $0.32 | $0.30 |
| Q1 2026 | 1 | $0.24 | $0.27 | $0.26 |
| Q2 2026 | 1 | $0.27 | $0.30 | $0.29 |
| Q3 2026 | 1 | $0.32 | $0.35 | $0.34 |
| Q4 2026 | 1 | $0.30 | $0.34 | $0.32 |
Evolent Health, Inc. Earnings Date And Information
Evolent Health, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.3 by $0.26. The company had revenue of 621.40 M for the quarter and had revenue of 1.96 B for the year. Evolent Health, Inc. has generated $-1 earnings per share over the last year ($-1.28 diluted earnings per share) and currently has a price-to-earnings ratio of -17.89. Evolent Health, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based on prior year's report dates.
Evolent Health, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.27 | $627.17 M | $621.40 M | ||
| 08/08/2024 | Q2 2024 | -$0.06 | $636.75 M | $647.15 M | ||
| 05/09/2024 | Q1 2024 | -$0.15 | $639.65 M | |||
| 02/22/2024 | Q4 2023 | -$0.29 | $556.06 M | |||
| 11/02/2023 | Q3 2023 | $0.09 | -$0.23 | -0.32 | $509.38 M | $511.02 M |
| 08/02/2023 | Q2 2023 | -$0.31 | $460.71 M | $469.14 M | ||
| 05/03/2023 | Q1 2023 | -$0.19 | $427.69 M | |||
| 02/24/2023 | Q4 2022 | -$0.11 | $382.43 M | |||
| 11/03/2022 | Q3 2022 | $0.02 | $356.76 M | $352.59 M | ||
| 08/03/2022 | Q2 2022 | -$0.05 | $298.79 M | $319.94 M | ||
| 05/04/2022 | Q1 2022 | -$0.06 | $297.06 M | |||
| 02/23/2022 | Q4 2021 | -$0.06 | $248.36 M | |||
| 11/03/2021 | Q3 2021 | -$0.15 | $226.00 M | $222.47 M | ||
| 08/04/2021 | Q2 2021 | -$0.11 | $216.56 M | $222.06 M | ||
| 05/05/2021 | Q1 2021 | -$0.12 | $215.07 M | |||
| 02/25/2021 | Q4 2020 | -$0.17 | $271.92 M | |||
| 11/05/2020 | Q3 2020 | -$0.44 | $263.78 M | $264.59 M | ||
| 08/07/2020 | Q2 2020 | -$2.38 | $241.17 M | $238.63 M | ||
| 05/27/2020 | Q1 2020 | -$0.92 | $247.29 M | |||
| 03/02/2020 | Q4 2019 | -$2.36 | $236.53 M |
Evolent Health, Inc. Earnings: Frequently Asked Questions
-
When is Evolent Health, Inc.'s earnings date?
Evolent Health, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 20th, 2025 based off last year's report dates.
-
How can I listen to Evolent Health, Inc.'s earnings conference call?
The conference call for Evolent Health, Inc.'s latest earnings report can be listened to online.
-
How can I read Evolent Health, Inc.'s conference call transcript?
The conference call transcript for Evolent Health, Inc.'s latest earnings report can be read online.
-
How much revenue does Evolent Health, Inc. generate each year?
Evolent Health, Inc. (:EVH) has a recorded annual revenue of $1.96 B.
-
How much profit does Evolent Health, Inc. generate each year?
Evolent Health, Inc. (:EVH) has a recorded net income of $1.96 B. Evolent Health, Inc. has generated $-1.28 earnings per share over the last four quarters.
-
What is Evolent Health, Inc.'s price-to-earnings ratio?
Evolent Health, Inc. (:EVH) has a price-to-earnings ratio of -17.89 and price/earnings-to-growth ratio is 3.26.
